PCN138 - COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER IN ENGLAND
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.221
https://www.valueinhealthjournal.com/article/S1098-3015(18)33521-6/fulltext
Title :
PCN138 - COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER IN ENGLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33521-6&doi=10.1016/j.jval.2018.09.221
First page :
Section Title :
Open access? :
No
Section Order :
1554